Statins Market Analysis & Forecasts to 2018 at RnRMarketResearch.com
W
Description
The report provides an in-depth analysis of the global statins market for dyslipidemia. The report gives insights into the share of generics in the global statins market for the years 2011 and 2018. The report examines the dyslipidemia treatment usage patterns in the US, the top five countries of Europe (The UK, France, Germany, Spain and Italy), and Japan. In addition to the global market landscape for statins, the report also provides details of the geographical distribution of statins sales in the major markets, including the US, the top five countries of Europe, and Japan.
Document Sample


Statins Market to 2018 – Weak Product Pipeline and
Shift of Focus towards Combination Therapies will
Lead to Erosion of Brand Share
http://www.rnrmarketresearch.com/statins-market-to-2018-
weak-product-pipeline-and-shift-of-focus-towards-
combination-therapies-will-lead-to-erosion-of-brand-share-
market-report.html
RnR Market Research
The leading business intelligence provider, has released its
latest research, “Statins Market to 2018 – Weak Product
Pipeline and Shift of Focus towards Combination Therapies will
Lead to Erosion of Brand Share”, which provides insights into
the global statins market until 2018. The report is built using
data and information sourced from proprietary databases,
primary and secondary research, and in-house analysis by GBI
Research’s team of industry experts. The report provides an in-
depth analysis of the global statins market for dyslipidemia. The
report gives insights into the share of generics in the global
statins market for the years 2011 and 2018. The report
examines the dyslipidemia treatment usage patterns in the US,
the top five countries of Europe (The UK, France, Germany,
Spain and Italy), and Japan. In addition to the global market
landscape for statins, the report also provides details of the
geographical distribution of statins sales in the major markets,
including the US, the top five countries of Europe, and Japan.
Request a sample copy of this report @
http://www.rnrmarketresearch.com/contacts/request-
sample?rname=69509
RnR Market Research
Reasons to buy
- Align their product portfolio to the markets with high growth potential
- Build effective strategies to launch their pipeline products by identifying
potential geographies
- Exploit in-licensing and out-licensing opportunities by identifying
products that might fill their portfolio gaps
- Develop key strategic initiatives by studying the key strategies of top
competitors
- Devise more tailored country-specific strategies through the
understanding of key drivers and barriers and the market potential of each
indication for different territories
- Develop market-entry and market expansion strategies by identifying the
geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can
produce first-in-class molecules which are safer and more efficacious
Buy report copy @
http://www.rnrmarketresearch.com/contacts/purchase?rn
ame=69509
Thank You
sales@rnrmarketresearch.com / +18883915441
RnR Market Research
Get documents about "